Premium meningitis vaccine Bexsero lands in hospitals in KOR
By Eo, Yun-Ho | translator Alice Kang
24.11.18 05:35:00
가나다라
0
Passes drug committees of 20 medical institutions in Korea, including the ‘Big 5’ tertiary hospitals
Proportion of serogroup B patients increases to 78% in Korea...raising the need for a serogroup B vaccine
The next-generation meningococcal vaccine, ‘Bexsero’ can now be prescribed in general hospitals in Korea.
According to industry sources, GSK Korea’s Bexsero, the first meningococcal B vaccine introduced to Korea, has passed the drug committees (DCs) of the Big 5 tertiary hospitals, including Samsung Medical Center, Seoul National University Hospital, Seoul St. Mary's Hospital, Seoul Asan Medical Center, and Sinchon Severance Hospital.
Kyungpook National University Hospital, Korea University Anam Hospital, Korea University Ansan Hospital, Inje University Paik Hospital, Seoul National University Bundang Hospital, Seogwipo Medical Center, Ajou University Hospital,
Eo, Yun-Ho(unkindfish@dailypharm.com)
If you want to see the full article, please JOIN US (click)